EUCTR2006-006754-10-FR进行中（未招募）1 期
Efficacy and safety of gliclazide MR (30 to 120 mg per day) associated or not to metformine or to an a-glucosidase inhibitor during the fast of the Ramadan in type 2 diabetic patients.A 5 to 8 months, national, multicentre, open study.Efficacité et tolérance du gliclazide LM (30 à 120 mg/j per os) associé ou non à la metformine ou à un inhibiteur des a-glucosidases pendant le jeûne du Ramadan chez des patients diabétiques de type 2. Etude nationale, multicentrique de 5 à 8 mois de traitement en ouvert.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Male or female aged > 35 years inclusive,
- •- Type 2 diabetic outpatients
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Type 1 diabetes
- •- Pregnancy, breast-feeding or female of childbearing potential,
- •- Contra-indication to gliclazide,
- •- Recent major cardiovascular events.
研究者
相似试验
招募中
不适用
Clinical Trial of Gliclazide in MODY 1,3 and 12CTRI/2020/03/023968DrVMohan
已完成
Unknown
Bioequivalence study of Gliclazide 30 mg Extended Release Tablet (Darou Darman Ariya Sepahan) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersBioequivalence study of Gliclazide 30 mg Extended Release Tablet (Darou Darman Ariya Sepahan) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteers.IRCT20220111053692N9Aria Sepahan Pharmaceutical Co24
已完成
Unknown
Bioequivalence study of Gliclazide 30 mg Extended Release Tablet (Tehran Chemie) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersBioequivalence study of Gliclazide 30 mg Extended Release Tablet (Tehran Chemie) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteers.IRCT20220111053692N10Tehran Chemie Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of Gliclazide 60 mg Extended Release Tablet (Tehran Chemie) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersIRCT20220111053692N7Tehran Chemie Pharmaceutical Company24
已完成
不适用
Bioequivalence study of Gliclazide 60 mg Extended Release Tablet (Darou Darman Ariya Sepahan) versus Diamicron MR (SERVIER) Tablet after single oral dosing in healthy volunteersIRCT20220111053692N6Aria Sepahan Pharmaceutical Co24